Empagliflozin attenuates arrhythmogenesis via inhibition of O-GlcNAcylation in diastolic phase of diabetic cardiomyopathy.

Back

ESC Professional Premium Access

Empagliflozin attenuates arrhythmogenesis via inhibition of O-GlcNAcylation in diastolic phase of diabetic cardiomyopathy.

Session: Mechanisms of ventricular arrhythmias

Topic: Arrhythmias

Speaker: Doctor T. Kadosaka (Sapporo, JP)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Takahide Kadosaka

Hokkaido University, Sapporo (Japan)

0 follower

7 more presentations in this session

Synapsin 2 regulates NCX1 trafficking and is down-regulated in the failing myocardium, which increases the risk of ventricular arrhythmia and heart failure mortality

Speaker: Doctor A. Ottesen (Nordbyhagen, NO)

Access

Abstract

Slides

Disease-associated calmodulin mutations disrupt L-type Ca2+ channel (Cav1.2) activity and CaMKIIdelta phosphorylation in long QT syndrome

Speaker: Assistant Professor N. Helassa (Liverpool, GB)

Access

Abstract

Slides

Long QT syndrome-associated calmodulin mutations and their interactions with the Kv7.1 voltage-gated potassium channel

Speaker: Mr L. McCormick (Leeds, GB)

Access

Abstract

Slides

Utility of in vivo zebrafish cardiac assay to predict the functional impact of KCNQ1 variants

Speaker: Mr S. Cui (Kanazawa, JP)

Access

Abstract

Slides

Acute afterload leads to increased electrophysiological heterogeneity after myocardial infarction.

Speaker: Doctor S. Ingelaere (Leuven, BE)

Access

Abstract

Slides

Access the full session

Mechanisms of ventricular arrhythmias

Speakers: Doctor T. Kadosaka, Doctor A. Ottesen, Assistant Professor N. Helassa, Mr L. McCormick, Mr S. Cui...

Access

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources